The most common cause of abacterial pneumoniaisStreptococcuspneumoniae. In this form of pneumonia, there is usually an abrupt onset of the illness with shaking chills, fever, and production of a rust-colored sputum. The infection spreads into the blood in 20%-30% of cases (known assepsis), ...
▌参考文献: [1]Platt Andrew, et al.185: PREVALENCE OF BACTERIAL AND FUNGAL COINFECTIONS IN A COVID-19 AUTOPSY CASE SERIES.#SCCM2022 [2]Singh Vishal, et al.215: A RARE INFECTION FOLLOWING COVID-19 PNEUMONIA TREATMENT.#SCCM2022 [3]Rivosecchi Ryan, et al.201: HIGH RATES OF INVASIVE FUN...
PNEUMONIAPOLYMERASE chain reactionBackground The evaluation of coronavirus disease 2019 (COVID-19) patients with respiratory secondary bacterial infection, and the causative pathogens, is crucial for the treatment plan of those patients and to ensure the effective needed treatment wit...
55.Langford,B.J.;So,M.;Raybardhan,S.;Leung,V.;Westwood,D.;MacFadden,D.R.;Soucy,J.-P.R.;Daneman,N.Bacterialco-infectionandsecondaryinfectioninpatientswithCOVID-19:Alivingrapidreviewandmeta-analysis.Clin.Microbiol.Infect.2020,26,1622-1...
Therefore, Chinese medicine treatment has positive impact on infectious lung diseases, as well as the development of new medicines. Conclusion Traditional Chinese medicine has a systemic theoretical understanding on the pathological evolution of novel coronavirus pneumonia and plays a positive role in NCP...
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While COVID-19 is asymptomatic in most individuals, it can cause symptoms like pneumonia, ARDS (acute respir
Gao, J.; Tian, Z.; Yang, X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.Biosci. Trends2020,14, 72–73. [Google Scholar] [CrossRef] [Green Version] ...
64.Horowitz,R.I.;Freeman,P.R.;Bruzzese,J.EfficacyofGlutathioneTherapyinRelievingDyspneaAssociatedwithCOVID-19Pneumonia:AReportof2Cases.Respir.Med.CaseRep.2020,30,101063.[GoogleScholar][CrossRef][PubMed] 65.Vitiello,A.;Troiano,V.;LaPorta,R.WhatwillbetheroleofmolnupiravirinthetreatmentofCOVID-...
(Ct), inflammatory factors C-reactive protein (CRP), procalcitonin, and IL-6, and serum antibody titer (IgG, IgM, and neutralizing antibodies); data from chest imaging studies; and information on complications, such as acute respiratory distress syndrome (ARDS), bacterial pneumonia, and multiple...
Additionally, IFN-β is currently recommended as a promising treatment option in some severe cases of COVID-19 [8]. Recombinant IFN-β is produced in both animal and bacterial hosts known as IFN-β 1-a and IFN-β 1-b, respectively. Thus, IFN-β 1-a, not IFN-β 1-b, is ...